Security Snapshot

SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) Institutional Ownership

CUSIP: 85209E208

13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

42

Shares (Excl. Options)

1.45MFull value: 1,445,415 · shares · 30 Sep 2026

Price

$48.58

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-94,572
Value change
-$5,183,505
Number of holders
42
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
2,892,857
SEC-reported price per share
$45.15
Insider filing price
$45.15
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SPRB - SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 85209E208.
  • 42 institutions reported positions in Q3 2026.
  • 14 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 64 to 42 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $108.32MFull value: $108,323,532 · USD · 30 Jun 2026
    to
    $70.22MFull value: $70,218,925 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 42 institutions filings for Q3 2026.

Open SEC evidence

Security key

85209E208

13F reference period

Q3 2026

13F holders

42

13D/G owners

14

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
14
Security
SPRB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.1% $13,500,000 250,000 Orin Hirschman 30 Jun 2026
BlackRock, Inc. 6.8% $10,143,144 187,836 BlackRock, Inc. 30 Jun 2026
ORBIMED ADVISORS LLC 5.6% +16% $7,314,300 +$1,345,470 162,000 +23% OrbiMed Advisors LLC 30 Sep 2026
INTEGRATED CORE STRATEGIES (US) LLC 5.8% -38% $7,788,261 +$2,803,863 160,981 +56% Integrated Core Strategies (US) LLC 30 Jun 2026
AWM Investment Company, Inc. 5.1% $7,111,279 146,988 AWM Investment Company, Inc. 30 Jun 2026
Ikarian Capital, LLC 11% -46% $1,060,227 121,356 0% Ikarian Capital, LLC 31 Oct 2025
Boone Peter David Mr 6.4% $8,045,712 68,184 Boone Peter David Mr 21 Nov 2025
ADAR1 Capital Management, LLC 2.5% -58% $3,276,148 +$470,108 67,717 +17% ADAR1 Capital Management, LLC 30 Jun 2026
Alyeska Investment Group, L.P. 4.5% -22% $3,978,332 61,670 0% Alyeska Investment Group, L.P. 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP 5.5% $4,804,344 58,949 Wellington Management Group LLP 31 Dec 2025
CITADEL ADVISORS LLC 1.9% -66% $2,511,841 -$876,452 51,919 -26% Kenneth Griffin 30 Jun 2026
Carlyle Group Inc. 4.7% $4,208,342 50,893 The Carlyle Group Inc. 18 Feb 2026
HealthCap VIII, L.P. 3.4% $335,256 36,640 HealthCap VIII, L.P. 07 Oct 2025
Squadron Capital Management LLC 0.9% -80% $787,022 -$3,728,678 12,200 -83% Squadron Master Fund LP 31 Mar 2026
As of 30 Sep 2026, 42 institutional investors reported holding
1.45MFull value: 1,445,415 · shares · 30 Sep 2026
shares of SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB). This represents 50% of the company’s total
2.89MFull value: 2,892,857 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
43%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AIGH Capital Management LLC 8.6% 250,000 1.4% $12,145,000
ORBIMED ADVISORS LLC 8.4% 242,800 0.22% $11,795,224
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 119,331 0% $5,797,100
Ikarian Capital, LLC 3.5% 101,356 0.99% $4,923,874
GEODE CAPITAL MANAGEMENT, LLC 2.3% 66,757 0% $3,244,123
Cable Car Capital, LP 2.1% 60,000 0.85% $2,914,800
STATE STREET CORP 2% 59,032 0% $2,867,775
Alyeska Investment Group, L.P. 1.8% 51,671 0.01% $2,510,177
Point72 Asset Management, L.P. 1.5% 44,258 0% $2,150,054
DIADEMA PARTNERS LP 1.4% 40,435 0.9% $1,964,332
Eversept Partners, LP 1.4% 39,840 0.11% $1,935,427
Quinn Opportunity Partners LLC 0.93% 26,810 0.07% $1,302,430
Knott David M Jr 0.9% 26,085 0.69% $1,267,209
ExodusPoint Capital Management, LP 0.76% 22,000 0.01% $1,068,760
XTX Topco Ltd 0.68% 19,690 0.01% $956,540
VANGUARD FIDUCIARY TRUST CO 0.66% 19,077 0% $926,761
VANGUARD PORTFOLIO MANAGEMENT LLC 0.59% 17,180 0% $834,604
Engineers Gate Manager LP 0.33% 9,636 0.01% $468,116
DIMENSIONAL FUND ADVISORS LP 0.3% 8,788 0% $426,399
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.25% 7,182 0% $348,902
GOLDMAN SACHS GROUP INC 0.23% 6,766 0% $328,692
NEW YORK STATE COMMON RETIREMENT FUND 0.07% 1,900 0% $92,302
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.04% 1,192 0% $57,907
Vanguard Global Advisers, LLC 0.04% 1,133 0% $55,041
Lion Point Capital, LP 0.03% 1,000 0.28% $48,580

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
5
Headline period
Q3 2026
Rows shown
1-5 of 5
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,445,415 $70,218,925 -$5,183,505 $48.58 42
2026 Q2 2,005,949 $108,323,532 +$67,610,654 $54.00 64
2026 Q1 739,765 $48,344,484 -$3,009,590 $65.35 32
2025 Q4 753,855 $65,599,507 -$189,602,432 $87.11 32
2025 Q3 2,937,895 $25,135,295 +$25,135,295 $8.95 9
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .